[424B3] US BANCORP \DE\ Prospectus Filed Pursuant to Rule 424(b)(3)
Rhea-AI Filing Summary
U.S. Bancorp is offering callable Senior Medium-Term Notes due June 12, 2046 under a prospectus and a pricing supplement dated June 2, 2026. The Notes carry a fixed interest rate of 6.00% per annum, pay interest annually on the 12th of June beginning June 12, 2027, and have a minimum denomination of $1,000.
The issuer may redeem the Notes, in whole but not in part, on scheduled quarterly Redemption Dates (March 12, June 12, September 12 and December 12) beginning June 12, 2027, at a redemption price equal to 100% of principal plus accrued interest. The per-Note price to the public is shown at $1,000 per $1,000 principal amount (with institutional/fee-based accounts able to purchase between $960.00 and $1,000). USBI, an affiliate and FINRA member, is participating in distribution and may receive selling commissions up to $40.00 per $1,000.
Positive
- None.
Negative
- None.
Insights
6.00% fixed, 20-year callable senior note with quarterly call dates.
The Notes pay 6.00% annually on each June 12 beginning June 12, 2027 and mature on June 12, 2046. The issuer may redeem in whole on specified quarterly Redemption Dates at 100% of principal plus accrued interest.
Key practical points: timing of any call will determine actual investor yield; the Notes rank as senior unsecured, so recoveries in stress depend on the issuer's general creditors. Secondary-market pricing will reflect call probability and prevailing rates.
Distribution involves an affiliate under FINRA Rule 5121 with disclosed conflicts.
The pricing supplement discloses that USBI, an affiliate, participates in distribution and may receive commissions up to $40.00 per $1,000 Note; sales to discretionary accounts require customer approval under FINRA Rule 5121. The offering complies with applicable FINRA requirements.
Prospective purchasers should review the incorporated "Risk Factors" and federal income tax summary; legal opinions and delivery mechanics (book-entry via DTC) are specified in the supplement.
